À
A Deacetylation–Diazotation–Coupling Sequence: Palladium-Catalyzed C C Bond Formation
(0); MS (EI): m/z=76 (5%), 151 (12%), 179 ([M]+, 100%);
HR-MS (EI): m/z=179.0725; calcd. for C13H9N+ [M]+:
179.0735.
4’-Methoxybiphenyl-4-carbonitrile (8db):[77] Following the
general procedure, 8db was obtained from 1d (240 mg,
1.5 mmol) and 7b (321 mg, 1.5 mmol) as a colourless solid;
yield: 85 mg (27%); mp 108–1118C, along with 9b [yield:
3-(Trifluoromethyl)biphenyl (8ea):[74] Following the gener-
al procedure, 8ea was obtained from 1e (305 mg, 1.5 mmol)
and 7a (276 mg, 1.5 mmol) as a colourless liquid; yield:
1
42 mg (13%)]. H NMR (300 MHz, CDCl3): d=7.69 (d, J=
8.6 Hz, 2H), 7.63 (d, J=8.6 Hz, 2H), 7.54 (d, J=8.8 Hz,
2H), 7.01 (d, J=8.8 Hz, 2H), 3.86 (s, 3H); 13C NMR
(75 MHz, CDCl3): d=160.3 (0), 145.3 (0), 132.6 (1), 131.6
(0), 128.4 (1), 127.2 (1), 119.1 (0), 114.7 (1), 110.2 (0), 55.5
(3); MS (EI): m/z=166 (28%), 194 (25%), 209 ([M]+,
100%); HR-MS (EI): m/z=209.0842, calcd. for C14H11NO+
[M]+: 209.0841.
1
72 mg (22%), along with 9a [yield: 81 mg (35%)]. H NMR
(300 MHz, CDCl3): d=7.85 (s, 1H), 7.78 (d, J=7.5 Hz, 1H),
7.74–7.30 (6H); 13C NMR (75 MHz, CDCl3); d=142.2 (0),
3
139.9 (0), 131.2 (q, JCF =32.0, 0), 130.5 (1), 129.3 (1), 129.1
1
(1), 128.1 (1), 127.3 (1), 124.4 (q, JC,F =272 Hz, 0), 124.2–
123.9 (2C, 1); MS (EI): m/z=152 (24%), 201 (18%), 222
([M]+, 100%); HR-MS (EI): m/z=222.0665, calcd. for
1-(4’-Fluorobiphenyl-4-yl)ethanone (8ac):[78] Following the
general procedure, 8ac was obtained from 1a (266 mg,
1.5 mmol) and 7c (303 mg, 1.5 mmol) as a colourless solid;
yield: 201 mg (63%); mp 100–1048C. 1H NMR (300 MHz,
CDCl3): d=8.03 (d, J=8.5 Hz, 2H), 7.63 (d, J=8.5 Hz, 2H),
7.62–7.55 (m, 2H), 7.16 (dd, J=8.7, 8.7 Hz, 2H), 2.64 (s,
3H); 13C NMR (75 MHz, CDCl3): d=197.7 (0), 163.0 (d,
+
C13H9F3 [M]+: 222.0656.
4-Nitrobiphenyl (8fa):[73] Following the general procedure,
8fa was obtained from 1f (270 mg, 1.5 mmol) and 7a
(276 mg, 1.5 mmol) as a colourless solid; yield: 170 mg
(47%); mp 1138C, along with nitrobenzene [yield: 27 mg
1
(15%)]. H NMR (300 MHz, CDCl3): d=8.30 (d, J=8.5 Hz,
4
1JC,F =248 Hz, 0), 144.8 (0), 136.1 (d, JC,F =3.3 Hz, 2C, 1),
2H), 7.74 (d, J=8.5 Hz, 2H), 7.70–7.57 (2H), 7.57–7.40
(3H); 13C NMR (75 MHz, CDCl3): d=147.7 (0), 147.2 (0),
138.9 (0), 129.2 (1), 129.0 (0), 127.9 (1), 127.5 (1), 124.2 (1);
MS (EI): m/z=115 (10%), 152 (64%), 169 (29%), 199
([M]+, 100%); HR-MS (EI): m/z=199.0633, calcd. for
136.0 (0), 129.1 (1), 129.0 (d, 3JC,F =7.7 Hz, 1), 127.2 (1),
116.0 (d, 2JC,F =21.6 Hz, 0), 26.7 (3); MS (EI): m/z=85
(7%), 170 (43%), 199 (100%), 214 ([M]+, 50%); HR-MS
(EI): m/z=214.0792, calcd. for C14H11OF+ [M]+: 214.0794.
4-Fluoro-4’-cyanobiphenyl (8dc): Following the general
procedure, 8dc was obtained from 1d (240 mg, 1.5 mmol)
and 7c (303 mg, 1.5 mmol) as a colourless solid; yield:
193 mg (65%); mp 110–1158C, along with 9c [yield: 28 mg
+
C12H9NO2 [M]+: 199.0633.
3-Bromobiphenyl-4-ol (8ma):[26] Following the general
procedure, 8ma was obtained from 1m (345 mg, 1.5 mmol)
and 7a (276 mg, 1.5 mmol) as a colourless solid; yield: 76 mg
(20%); mp 94–998C, along with 9a [yield: 53 mg (23%)].
1H NMR (300 MHz, CDCl3): d=7.71 (d, J=2.1, 1H), 7.57–
7.49 (2H), 7.49–7.38 (3H), 7.34 (tt, J=7.2, 2.3, 1H), 7.10 (d,
J=8.4, 1H), 5.54 (s, 1H); 13C NMR (75 MHz, CDCl3): d=
151.8 (0), 139.5 (0), 135.5 (0), 130.5 (1), 128.9 (1), 128.0 (1),
127.3 (1), 126.8 (1), 116.4 (1), 110.7 (0); MS (EI): m/z=115
(28%), 139 (80%), 170 (11%), 248 ([M]+, 100%); HR-MS
(EI): m/z=247.9820, calcd. for C12H9O79Br+ [M]+: 247.9837.
3-Bomo-4-methoxybiphenyl (8na):[75] Following the gener-
al procedure, 8na obtained from 1n (366 mg, 1.5 mmol) and
7a (276 mg, 1.5 mmol) as a colourless solid; yield: 128 mg
(32%), mp 808C; along with 9a [yield: 53 mg (23%)].
1H NMR (300 MHz, CDCl3): d=7.80 (d, J=2.2 Hz, 1H),
7.59–7.47 (3H), 7.43 (m, 2H), 7.33 (m, 1H), 6.97 (d, J=
8.5 Hz, 1H), 3.94 (s, 3H); 13C NMR (75 MHz, CDCl3): d=
155.4 (0), 139.5 (0), 135.3 (0), 132.0 (1), 128.9 (1), 127.3 (1),
127.1 (1), 126.8 (1), 112.2 (1), 112.1 (0), 56.4 (3); MS (EI):
m/z=139 (48%), 219 (25%), 247 (43%), 262 ([M]+, 100%);
HR-MS (EI): m/z=261.9978, calcd. for C13H11OBr+ [M]+:
261.9993; anal. calcd. for C13H11OBr: C 59.3%, H 4.2%;
found: C 59.4%, H 4.0%; IR (KBr): n=1595 (m), 1484 (s),
1282 (s), 1270 (s) cmÀ1.
1
(10%)]. H NMR (300 MHz, CDCl3): d=7.72 (d, J=8.6 Hz,
2H), 7.64 (d, J=8.6 Hz, 2H), 7.56 (dd, J=8.9, 5.2 Hz, 2H),
7.17 (dd, J=8.7, 8.7 Hz, 2H); 13C NMR (75 MHz, CDCl3):
4
d=163.3 (d, 1JC,F =249 Hz, 0), 144.7 (0), 135.4 (d, JC,F
=
3.3 Hz, 0), 132.7 (1), 129.1 (d, 3JC,F =8.3 Hz, 1), 127.6 (1),
118.9 (0), 116.2 (d, JCF =21.7, 1), 111.0 (0); MS (EI): m/z=
2
85 (5%), 98 (4%), 170 (9%), 197 ([M]+, 100%); HR-MS
(EI): m/z=197.0636, calcd. for C13H8NF+ [M]+: 197.0641.
4-Fluoro-4’-nitrobiphenyl (8fc):[73] Following the general
procedure, 8fc was obtained from 1f (270 mg, 1.5 mmol)
and 7c (303 mg, 1.5 mmol) as a colourless solid; yield:
200 mg (61%), mp 124–1288C, along with 9c [yield: 28 mg
1
(10%)]. H NMR (300 MHz, CDCl3): d=8.29 (d, J=8.9 Hz,
2H), 7.69 (d, J=8.9 Hz, 2H), 7.60 (dd, J=8.9 Hz, 5.2, 2H),
7.19 (dd, J=8.6, 8.6 Hz, 2H); 13C NMR (75 MHz, CDCl3):
1
d=163.4 (d, JC,F =250 Hz, 0), 147.2 (0) 146.7 (0), 135.0 (d,
3
4JC,F =3.3 Hz, 0), 129.3 (d, JC,F =8.3 Hz, 1), 127.7 (1), 124.3
2
(1), 116.3 (d, JC,F =21.7 Hz, 1); MS (EI): m/z=159 (33%),
170 (79%), 187 (40%), 217 ([M]+, 100%); HR-MS (EI):
m/z=217.0544, calcd. for C12H8NO2F+ [M]+: 217.0539.
4’-Chloro-3-nitrobiphenyl (8hd):[79] Following the general
procedure, 8hd was obtained from 1h (255 mg, 1.5 mmol)
and 7d (344 mg, 1.5 mmol) as a colourless solid; yield:
84 mg (24%), mp 90–938C, along with 9d [yield: 59 mg
(16%)]. 1H NMR (300 MHz, CDCl3): d=8.39 (dd, J=1.9,
1.9 Hz, 1H), 8.20 (ddd, J=8.2, 2.2, 1.0 Hz, 1H), 7.87 (ddd,
J=7.8, 1.7, 1.0 Hz, 1H), 7.61 (dd, J=8.0, 8.0 Hz, 1H), 7.55
(d, J=8.7 Hz, 2H), 7.45 (d, J=8.7 Hz, 2H); 13C NMR
(75 MHz, CDCl3): d=148.8 (0), 141.6 (0), 137.1 (0), 134.9
(0), 132.9 (1), 129.9 (1), 129.4 (1), 128.4 (1), 122.4 (1), 121.8
(1); MS (EI): m/z=126 (8%), 152 (100%), 187 (9%), 233
([M]+, 61%); HR-MS (EI): m/z=233.0250, calcd. for
C12H8NO235Cl+ [M]+: 233.0244.
1-(4’-Methoxybiphenyl-4-yl)ethanone (8ab):[76] Following
the general procedure, 8ab was obtained from 1a (266 mg,
1.5 mmol) and 7b (321 mg, 1.5 mmol) as a colourless solid;
yield: 138 mg (41%); mp 155–1588C, along with 9b [yield:
1
42 mg (13%)]. H NMR (300 MHz, CDCl3): d=8.01 (d, J=
8.5 Hz, 2H), 7.64 (d, J=8.5 Hz, 2H), 7.58 (d, J=8.8 Hz,
2H), 7.00 (d, J=8.8 Hz, 2H), 3.86 (s, 3H), 2.63 (s, 3H);
13C NMR (75 MHz, CDCl3): d=197.8 (0), 160.0 (0), 145.5
(0), 135.4 (0), 132.4 (0), 129.0 (1), 128.5 (1), 126.7 (1), 114.5
(1), 55.5 (3), 26.7 (3); MS (EI): m/z=139 (26%), 211
(100%), 226 ([M]+, 76%); HR-MS (EI): m/z=226.0980,
+
calcd. for C15H14O2 [M]+: 226.0994.
Adv. Synth. Catal. 2013, 355, 463 – 476
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
473